JP2009502364A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009502364A5 JP2009502364A5 JP2008524266A JP2008524266A JP2009502364A5 JP 2009502364 A5 JP2009502364 A5 JP 2009502364A5 JP 2008524266 A JP2008524266 A JP 2008524266A JP 2008524266 A JP2008524266 A JP 2008524266A JP 2009502364 A5 JP2009502364 A5 JP 2009502364A5
- Authority
- JP
- Japan
- Prior art keywords
- article
- manufacture
- plasticizer
- product
- porogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000004519 manufacturing process Methods 0.000 claims 23
- 239000004014 plasticizer Substances 0.000 claims 10
- 229920001222 biopolymer Polymers 0.000 claims 9
- 239000000203 mixture Substances 0.000 claims 9
- 239000003361 porogen Substances 0.000 claims 9
- AZKVWQKMDGGDSV-BCMRRPTOSA-N Genipin Chemical compound COC(=O)C1=CO[C@@H](O)[C@@H]2C(CO)=CC[C@H]12 AZKVWQKMDGGDSV-BCMRRPTOSA-N 0.000 claims 8
- 239000003431 cross linking reagent Substances 0.000 claims 7
- BJHIKXHVCXFQLS-UYFOZJQFSA-N Fructose Natural products OC[C@@H](O)[C@@H](O)[C@H](O)C(=O)CO BJHIKXHVCXFQLS-UYFOZJQFSA-N 0.000 claims 6
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 claims 6
- WSFSSNUMVMOOMR-UHFFFAOYSA-N formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 claims 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims 4
- 239000011159 matrix material Substances 0.000 claims 4
- 229920000642 polymer Polymers 0.000 claims 4
- 108010071289 Factor XIII Proteins 0.000 claims 3
- 239000005715 Fructose Substances 0.000 claims 3
- OJVAMHKKJGICOG-UHFFFAOYSA-N Hexane-2,5-dione Chemical compound CC(=O)CCC(C)=O OJVAMHKKJGICOG-UHFFFAOYSA-N 0.000 claims 3
- ZIUHHBKFKCYYJD-UHFFFAOYSA-N N,N'-Methylenebisacrylamide Chemical compound C=CC(=O)NCNC(=O)C=C ZIUHHBKFKCYYJD-UHFFFAOYSA-N 0.000 claims 3
- HRPVXLWXLXDGHG-UHFFFAOYSA-N acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 claims 3
- 150000001718 carbodiimides Chemical class 0.000 claims 3
- 238000004132 cross linking Methods 0.000 claims 3
- 150000001990 dicarboxylic acid derivatives Chemical class 0.000 claims 3
- FRTGEIHSCHXMTI-UHFFFAOYSA-N dimethyl octanediimidate Chemical compound COC(=N)CCCCCCC(=N)OC FRTGEIHSCHXMTI-UHFFFAOYSA-N 0.000 claims 3
- XLNOKJLJDWVOQP-UHFFFAOYSA-L disodium;formaldehyde;sulfite Chemical compound [Na+].[Na+].O=C.[O-]S([O-])=O XLNOKJLJDWVOQP-UHFFFAOYSA-L 0.000 claims 3
- 150000002148 esters Chemical class 0.000 claims 3
- 229940012444 factor XIII Drugs 0.000 claims 3
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 claims 3
- XFIOZCMKPNZOII-RJMCEWFISA-N methyl (1S,4aS,7R,7aS)-4'-(hydroxymethyl)-5'-oxo-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyspiro[4a,7a-dihydro-1H-cyclopenta[c]pyran-7,2'-furan]-4-carboxylate Chemical class O([C@@H]1OC=C([C@@H]2[C@H]1[C@]1(C=C(CO)C(=O)O1)C=C2)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O XFIOZCMKPNZOII-RJMCEWFISA-N 0.000 claims 3
- 239000004033 plastic Substances 0.000 claims 3
- 229920003023 plastic Polymers 0.000 claims 3
- 239000000843 powder Substances 0.000 claims 3
- 239000007787 solid Substances 0.000 claims 3
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide Chemical compound CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 claims 2
- PRKQVKDSMLBJBJ-UHFFFAOYSA-N Ammonium carbonate Chemical compound N.N.OC(O)=O PRKQVKDSMLBJBJ-UHFFFAOYSA-N 0.000 claims 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L Calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 claims 2
- QORWJWZARLRLPR-UHFFFAOYSA-H Tricalcium phosphate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 claims 2
- 150000001412 amines Chemical class 0.000 claims 2
- 239000001099 ammonium carbonate Substances 0.000 claims 2
- 239000001506 calcium phosphate Substances 0.000 claims 2
- 150000001875 compounds Chemical class 0.000 claims 2
- 238000007906 compression Methods 0.000 claims 2
- 238000001125 extrusion Methods 0.000 claims 2
- 235000011187 glycerol Nutrition 0.000 claims 2
- 239000000017 hydrogel Substances 0.000 claims 2
- 238000002347 injection Methods 0.000 claims 2
- 239000007924 injection Substances 0.000 claims 2
- 229920000160 (ribonucleotides)n+m Polymers 0.000 claims 1
- ISCMYZGMRHODRP-UHFFFAOYSA-N 3-(iminomethylideneamino)-N,N-dimethylpropan-1-amine Chemical compound CN(C)CCCN=C=N ISCMYZGMRHODRP-UHFFFAOYSA-N 0.000 claims 1
- 239000005695 Ammonium acetate Substances 0.000 claims 1
- 229910000013 Ammonium bicarbonate Inorganic materials 0.000 claims 1
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 claims 1
- 102000008186 Collagen Human genes 0.000 claims 1
- 108010035532 Collagen Proteins 0.000 claims 1
- 229940099371 DIACETYLATED MONOGLYCERIDES Drugs 0.000 claims 1
- 108010014258 Elastin Proteins 0.000 claims 1
- 102000016942 Elastin Human genes 0.000 claims 1
- 210000002744 Extracellular Matrix Anatomy 0.000 claims 1
- 229950003499 FIBRIN Drugs 0.000 claims 1
- 102000009123 Fibrin Human genes 0.000 claims 1
- 108010073385 Fibrin Proteins 0.000 claims 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 claims 1
- 108010049003 Fibrinogen Proteins 0.000 claims 1
- 102000008946 Fibrinogen Human genes 0.000 claims 1
- 229940012952 Fibrinogen Drugs 0.000 claims 1
- 229940019698 Fibrinogen containing hemostatics Drugs 0.000 claims 1
- 108010010803 Gelatin Proteins 0.000 claims 1
- 229940014259 Gelatin Drugs 0.000 claims 1
- 229940088597 Hormone Drugs 0.000 claims 1
- 229920000954 Polyglycolide Polymers 0.000 claims 1
- 239000004721 Polyphenylene oxide Substances 0.000 claims 1
- MGADZUXDNSDTHW-UHFFFAOYSA-N Pyran Chemical compound C1OC=CC=C1 MGADZUXDNSDTHW-UHFFFAOYSA-N 0.000 claims 1
- FDDDEECHVMSUSB-UHFFFAOYSA-N Sulfanilamide Chemical compound NC1=CC=C(S(N)(=O)=O)C=C1 FDDDEECHVMSUSB-UHFFFAOYSA-N 0.000 claims 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K [O-]P([O-])([O-])=O Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims 1
- WNLRTRBMVRJNCN-UHFFFAOYSA-L adipate(2-) Chemical compound [O-]C(=O)CCCCC([O-])=O WNLRTRBMVRJNCN-UHFFFAOYSA-L 0.000 claims 1
- -1 alkyl citrate Chemical compound 0.000 claims 1
- USFZMSVCRYTOJT-UHFFFAOYSA-N ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 claims 1
- 229940043376 ammonium acetate Drugs 0.000 claims 1
- 235000019257 ammonium acetate Nutrition 0.000 claims 1
- 235000012538 ammonium bicarbonate Nutrition 0.000 claims 1
- 235000012501 ammonium carbonate Nutrition 0.000 claims 1
- 235000019270 ammonium chloride Nutrition 0.000 claims 1
- 239000000427 antigen Substances 0.000 claims 1
- 102000038129 antigens Human genes 0.000 claims 1
- 108091007172 antigens Proteins 0.000 claims 1
- 239000008346 aqueous phase Substances 0.000 claims 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-M benzoate Chemical compound [O-]C(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-M 0.000 claims 1
- 229910000389 calcium phosphate Inorganic materials 0.000 claims 1
- 235000011010 calcium phosphates Nutrition 0.000 claims 1
- 235000011132 calcium sulphate Nutrition 0.000 claims 1
- 229920001436 collagen Polymers 0.000 claims 1
- 229960005188 collagen Drugs 0.000 claims 1
- 229920001577 copolymer Polymers 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 229940079593 drugs Drugs 0.000 claims 1
- 229920002549 elastin Polymers 0.000 claims 1
- 239000000945 filler Substances 0.000 claims 1
- 239000010419 fine particle Substances 0.000 claims 1
- 229920000159 gelatin Polymers 0.000 claims 1
- 239000008273 gelatin Substances 0.000 claims 1
- 235000019322 gelatine Nutrition 0.000 claims 1
- 235000011852 gelatine desserts Nutrition 0.000 claims 1
- 150000004676 glycans Polymers 0.000 claims 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims 1
- 239000005556 hormone Substances 0.000 claims 1
- 229920002674 hyaluronan Polymers 0.000 claims 1
- 229960003160 hyaluronic acid Drugs 0.000 claims 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 claims 1
- 239000000367 immunologic factor Substances 0.000 claims 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims 1
- VZCYOOQTPOCHFL-UPHRSURJSA-L maleate(2-) Chemical compound [O-]C(=O)\C=C/C([O-])=O VZCYOOQTPOCHFL-UPHRSURJSA-L 0.000 claims 1
- 239000011859 microparticle Substances 0.000 claims 1
- QDHHCQZDFGDHMP-UHFFFAOYSA-N monochloramine Chemical compound ClN QDHHCQZDFGDHMP-UHFFFAOYSA-N 0.000 claims 1
- 239000012074 organic phase Substances 0.000 claims 1
- 239000010452 phosphate Substances 0.000 claims 1
- 239000008029 phthalate plasticizer Substances 0.000 claims 1
- 229920000747 poly(lactic acid) polymer Polymers 0.000 claims 1
- 229920001610 polycaprolactone Polymers 0.000 claims 1
- 239000004632 polycaprolactone Substances 0.000 claims 1
- 229920000570 polyether Polymers 0.000 claims 1
- 239000004633 polyglycolic acid Substances 0.000 claims 1
- 239000004626 polylactic acid Substances 0.000 claims 1
- 229920001282 polysaccharide Polymers 0.000 claims 1
- 239000005017 polysaccharide Substances 0.000 claims 1
- 150000004804 polysaccharides Polymers 0.000 claims 1
- 229920002635 polyurethane Polymers 0.000 claims 1
- 239000004814 polyurethane Substances 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- NRTYMEPCRDJMPZ-UHFFFAOYSA-N pyridine;2,2,2-trifluoroacetic acid Chemical compound C1=CC=NC=C1.OC(=O)C(F)(F)F NRTYMEPCRDJMPZ-UHFFFAOYSA-N 0.000 claims 1
- 229940116351 sebacate Drugs 0.000 claims 1
- CXMXRPHRNRROMY-UHFFFAOYSA-L sebacate(2-) Chemical compound [O-]C(=O)CCCCCCCCC([O-])=O CXMXRPHRNRROMY-UHFFFAOYSA-L 0.000 claims 1
- MAKUBRYLFHZREJ-JWBQXVCJSA-M sodium;(2S,3S,4R,5R,6R)-3-[(2S,3R,5S,6R)-3-acetamido-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5,6-trihydroxyoxane-2-carboxylate Chemical compound [Na+].CC(=O)N[C@@H]1C[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](C([O-])=O)O[C@@H](O)[C@H](O)[C@H]1O MAKUBRYLFHZREJ-JWBQXVCJSA-M 0.000 claims 1
- 239000002904 solvent Substances 0.000 claims 1
- 229960001663 sulfanilamide Drugs 0.000 claims 1
- 229910000391 tricalcium phosphate Inorganic materials 0.000 claims 1
- 235000019731 tricalcium phosphate Nutrition 0.000 claims 1
- 229940078499 tricalcium phosphate Drugs 0.000 claims 1
- 125000005591 trimellitate group Chemical group 0.000 claims 1
- 238000001291 vacuum drying Methods 0.000 claims 1
- 235000015112 vegetable and seed oil Nutrition 0.000 claims 1
- 239000008158 vegetable oil Substances 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
Claims (36)
- バイオポリマーを含む製造品であって、イリドイド誘導体、ゲニピン、ジイミデート、ジオン、ジカルボン酸のNHSエステル、カルボジイミド、アクリルアミド、N,N’−メチレンビスアクリルアミド、糖、リボース、フルクトース、第XIII因子、1−エチル−3−(ジメチルアミノプロピル)カルボジイミド、2,5−ヘキサンジオン、ジメチルスベルイミデート、グルタルアルデヒド、ホルムアルデヒド、ホルムアルデヒド亜硫酸ナトリウム、およびそれらの組合せから成る群より選択される架橋剤により架橋され、脱水されている製造品。
- バイオポリマーを含む製造品であって、圧縮されている製造品。
- 前記製造品が、イリドイド誘導体、ゲニピン、ジイミデート、ジオン、ジカルボン酸のNHSエステル、カルボジイミド、アクリルアミド、N,N’−メチレンビスアクリルアミド、糖、リボース、フルクトース、第XIII因子、1−エチル−3−(ジメチルアミノプロピル)カルボジイミド、2,5−ヘキサンジオン、ジメチルスベルイミデート、グルタルアルデヒド、ホルムアルデヒド、ホルムアルデヒド亜硫酸ナトリウム、およびそれらの組合せから成る群より選択される架橋剤により架橋されている、請求項2に記載の製造品。
- 前記バイオポリマーがタンパク質、フィブリン、フィブリノゲン、コラーゲン、ゼラチン、エラスチン、細胞外マトリクス構成要素、ポリサッカライド、ヒアルロン酸、およびそれらの組合せから成る群より選択される、請求項1または2のいずれか1項に記載の製造品。
- 前記バイオポリマーが粉末である、請求項1または2のいずれか1項に記載の方法。
- 前記製造品が真空によって脱水されている、請求項1に記載の製造品。
- 前記製造品がフィルムを形成する、請求項1または2のいずれか1項に記載の製造品。
- 前記製造品がジスルフィド結合を含む、請求項1または2のいずれか1項に記載の製造品。
- 前記製造品がイソペプチド結合を含む、請求項1または2のいずれか1項に記載の製造品。
- 前記製造品がモノアルデヒド架橋アミンを含む、請求項1または2のいずれか1項に記載の製造品。
- 前記製造品がピラン架橋アミンを含む、請求項1または2のいずれか1項に記載の製造品。
- 前記架橋剤がゲニピンである、請求項1または3のいずれか1項に記載の製造品。
- 前記架橋剤が粉末である、請求項1または3のいずれか1項に記載の製造品。
- 前記製造品が生物学的応答調節物質、抗原、薬物、ホルモン、トレーサ、RNAおよびDNAから成る群より選択される化合物を含む、請求項1または2のいずれか1項に記載の製造品。
- 前記製造品が充填剤を含む、請求項1または2のいずれか1項に記載の製造品。
- 前記製造品が微粒子を含む、請求項15に記載の製造品。
- 前記微粒子がヒドロキシアパタイト、リン酸三カルシウム、リン酸カルシウム、および硫酸カルシウムから成る群より選択される、請求項16に記載の製造品。
- 請求項7に記載のフィルムを含む積層構造物である、製造品。
- 前記積層構造物がシートの積み重ね、管状ロール、またはそれらの組合せから形成される、請求項18に記載の製造品。
- 前記製造品が、プラスチックを形成するのに十分な圧力、温度、および時間、圧縮される、請求項2に記載の製造品。
- 前記製造品が押し出し金型、圧縮鋳型、または射出鋳型で形成される、請求項2に記載の製造品。
- 前記製造品が可塑剤を含む、請求項1または2のいずれか1項に記載の製造品。
- 前記可塑剤がフタレート可塑剤、アジペート可塑剤、トリメリテート可塑剤、マレエート可塑剤、セバケート可塑剤、ベンゾエート可塑剤、エポキシ化植物油、スルホンアミド可塑剤、ホスフェート可塑剤、水、ポリアルコール、グリコール、グリセリン、グリセロール、ポリエーテル、アセチル化モノグリセリド、アルキルシトレート、ポリマー可塑剤、およびそれらの組合せから成る群より選択される、請求項22に記載の製造品。
- 前記製造品が孔を含む、請求項2に記載の製造品。
- ハイドロゲルを供給する工程であって、該ハイドロゲルが、イリドイド誘導体、ゲニピン、ジイミデート、ジオン、ジカルボン酸のNHSエステル、カルボジイミド、アクリルアミド、N,N’−メチレンビスアクリルアミド、糖、リボース、フルクトース、第XIII因子、1−エチル−3−(ジメチルアミノプロピル)カルボジイミド、2,5−ヘキサンジオン、ジメチルスベルイミデート、グルタルアルデヒド、ホルムアルデヒド、ホルムアルデヒド亜硫酸ナトリウム、およびそれらの組合せから成る群より選択される架橋剤により架橋されている工程と;
脱水フィルムを形成するための温度および時間で該ハイドロゲルを真空乾燥させる工程と;
を含む、ポリマーフィルムを製造する方法。 - 前記温度が80℃未満である、請求項25に記載の方法。
- 前記圧力が20ミリバール未満である、請求項25に記載の方法。
- バイオポリマーと化合物とを混合し、混合物を作製する工程と;
該混合物を、バイオポリマーマトリックスを形成するための温度および時間、圧縮する工程と;
を含む、プラスチックを製造する方法。 - 前記温度が80℃未満である、請求項28に記載の方法。
- 前記混合物が押し出し金型、圧縮鋳型、または射出鋳型で形成される、請求項29に記載の方法。
- バイオポリマーに溶媒和ポロゲンまたは昇華ポロゲンを混合する工程と;
該ポロゲンを含むバイオポリマーマトリクスを形成する工程と;
該バイオポリマーマトリクスから該ポロゲンを除去する工程と;
を含む、多孔性プラスチックを製造する方法。 - 前記ポロゲンが有機相に溶解性である、請求項31に記載の方法。
- 前記ポロゲンがポリウレタン、ポリ乳酸、ポリグリコール酸、乳酸−グリコール酸コポリマー、およびポリカプロラクトンから選択される溶媒和ポロゲンである、請求項31に記載の方法。
- 前記ポロゲンが水相に溶解性である、請求項31に記載の方法。
- 前記ポロゲンが酢酸アンモニウム、塩化アンモニウム、重炭酸アンモニウム、炭酸アンモニウム、およびトリフルオロ酢酸ピリジニウムから成る群より選択される昇華ポロゲンである、請求項31に記載の方法。
- 溶媒により活性化させることができる固体架橋剤と混合された固体ポリマー粉末を提供し、混合物を形成する工程と;
該固体架橋剤を含む該混合物からポリマーマトリクスを形成する工程と;
を含む、ポリマーを架橋する方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US70320605P | 2005-07-28 | 2005-07-28 | |
US60/703,206 | 2005-07-28 | ||
PCT/US2006/029754 WO2007126411A2 (en) | 2005-07-28 | 2006-07-28 | Biocompatible polymers and methods of use |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2009502364A JP2009502364A (ja) | 2009-01-29 |
JP2009502364A5 true JP2009502364A5 (ja) | 2009-09-03 |
JP5475283B2 JP5475283B2 (ja) | 2014-04-16 |
Family
ID=38655940
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2008524266A Active JP5475283B2 (ja) | 2005-07-28 | 2006-07-28 | 生体適合性ポリマーおよび使用方法 |
Country Status (4)
Country | Link |
---|---|
EP (2) | EP2093256A3 (ja) |
JP (1) | JP5475283B2 (ja) |
CA (1) | CA2616865C (ja) |
WO (1) | WO2007126411A2 (ja) |
Families Citing this family (61)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8529956B2 (en) | 2002-03-18 | 2013-09-10 | Carnell Therapeutics Corporation | Methods and apparatus for manufacturing plasma based plastics and bioplastics produced therefrom |
US8293530B2 (en) * | 2006-10-17 | 2012-10-23 | Carnegie Mellon University | Method and apparatus for manufacturing plasma based plastics and bioplastics produced therefrom |
WO2005081970A2 (en) | 2004-02-24 | 2005-09-09 | The Curators Of The University Of Missouri | Self-assembling cell aggregates and methods of making engineered tissue using the same |
WO2007024618A1 (en) | 2005-08-22 | 2007-03-01 | Genencor International, Inc. | Composites of repeat sequence proteins and their preparation |
US20070184087A1 (en) * | 2006-02-06 | 2007-08-09 | Bioform Medical, Inc. | Polysaccharide compositions for use in tissue augmentation |
US8021677B2 (en) * | 2006-05-12 | 2011-09-20 | Gore Enterprise Holdings, Inc. | Immobilized biologically active entities having a high degree of biological activity |
US8529959B2 (en) | 2006-10-17 | 2013-09-10 | Carmell Therapeutics Corporation | Methods and apparatus for manufacturing plasma based plastics and bioplastics produced therefrom |
JP5581056B2 (ja) | 2006-12-15 | 2014-08-27 | ライフボンド リミテッド | ゼラチン−トランスグルタミナーゼ止血ドレッシング及びシーラント |
US20080154372A1 (en) * | 2006-12-21 | 2008-06-26 | Peckham Steven M | Osteochondral implant using a growth factor concentration gradient for repair of bone and cartilage tissue |
US20100234948A1 (en) * | 2009-03-11 | 2010-09-16 | Exogenesis Corporation | Methods for improving the bioactivity characteristics of a surface and objects with surfaces improved thereby |
WO2009105820A1 (en) * | 2008-02-29 | 2009-09-03 | The University Of Sydney | Hydrogels derived from biological polymers |
US8557319B2 (en) | 2008-03-28 | 2013-10-15 | Wild Flavors, Inc. | Stable natural color process, products and use thereof |
MY144571A (en) * | 2008-04-24 | 2011-10-14 | Univ Malaya | Extracellular scaffold |
JP5450612B2 (ja) | 2008-06-18 | 2014-03-26 | ライフボンド リミテッド | 改良された架橋組成物 |
JP5624981B2 (ja) | 2008-06-24 | 2014-11-12 | ザ・キュレーターズ・オブ・ザ・ユニバーシティ・オブ・ミズーリThe Curators Ofthe University Of Missouri | 自己集合性多細胞体、および前記多細胞体を用いて3次元の生物構造体を作製する方法 |
US9216188B2 (en) | 2008-09-04 | 2015-12-22 | The General Hospital Corporation | Hydrogels for vocal cord and soft tissue augmentation and repair |
WO2010076798A1 (en) * | 2009-01-02 | 2010-07-08 | Ramot At Tel Aviv University Ltd. | Fibrin and fibrinogen matrices and uses of same |
KR100932945B1 (ko) * | 2009-01-16 | 2009-12-21 | 원광대학교산학협력단 | 골 분말과 피브린 글루로 이루어진 고형의 스캐폴드 |
KR100932948B1 (ko) * | 2009-01-16 | 2009-12-21 | 원광대학교산학협력단 | Bmp-2를 함유하는 골 분말과 피브린 글루로 이루어진 고형의 스캐폴드 |
WO2010110067A1 (ja) * | 2009-03-27 | 2010-09-30 | 株式会社マルハニチロ食品 | エラスチン及びコラーゲンを用いた架橋物及びその用途 |
US8652500B2 (en) | 2009-07-22 | 2014-02-18 | Acell, Inc. | Particulate tissue graft with components of differing density and methods of making and using the same |
JP2012533373A (ja) * | 2009-07-23 | 2012-12-27 | プロゲンティックス・オーソバイオロジー・ベー・フェー | 注入及び成形可能な骨誘導性セラミック材料 |
US8357364B2 (en) * | 2009-09-15 | 2013-01-22 | University of Pittsburgh—of the Commonwealth System of Higher Education | Bone substitute compositions, methods of preparation and clinical applications |
EP2515957B1 (en) | 2009-12-22 | 2015-07-29 | Lifebond Ltd | Modification of enzymatic crosslinkers for controlling properties of crosslinked matrices |
WO2011109730A2 (en) | 2010-03-04 | 2011-09-09 | The General Hospital Corporation | Methods and systems of matching voice deficits with a tunable mucosal implant to restore and enhance individualized human sound and voice production |
CN103201324A (zh) * | 2010-05-10 | 2013-07-10 | 阿勒根公司 | 多孔材料、制备方法及用途 |
US11202853B2 (en) | 2010-05-11 | 2021-12-21 | Allergan, Inc. | Porogen compositions, methods of making and uses |
CN102985119B (zh) * | 2010-05-11 | 2015-02-11 | 阿勒根公司 | 多孔材料、制备方法及用途 |
US8961544B2 (en) | 2010-08-05 | 2015-02-24 | Lifebond Ltd. | Dry composition wound dressings and adhesives comprising gelatin and transglutaminase in a cross-linked matrix |
JP5721379B2 (ja) * | 2010-09-21 | 2015-05-20 | 学校法人同志社 | 親水性高分子を含む自動縫合器用縫合補強材 |
US9572907B2 (en) | 2010-10-01 | 2017-02-21 | Covidien Lp | Implantable polymeric films |
US9149952B2 (en) | 2010-10-21 | 2015-10-06 | Organovo, Inc. | Devices, systems, and methods for the fabrication of tissue |
US10864158B2 (en) | 2011-04-14 | 2020-12-15 | The Regents Of The University Of California | Multilayer thin film drug delivery device and methods of making and using the same |
JP2014525817A (ja) | 2011-08-22 | 2014-10-02 | エクソジェネシス コーポレーション | 物体表面の生物活性特徴の向上方法ならびにそれにより向上された表面 |
ES2640002T3 (es) | 2011-11-07 | 2017-10-31 | Wild Flavors, Inc. | Material rico en genipina y su uso |
WO2013112875A1 (en) * | 2012-01-25 | 2013-08-01 | The University Of Akron | Wound dressings with enhanced gas permeation and other beneficial properties |
US9499779B2 (en) | 2012-04-20 | 2016-11-22 | Organovo, Inc. | Devices, systems, and methods for the fabrication of tissue utilizing UV cross-linking |
US9442105B2 (en) | 2013-03-15 | 2016-09-13 | Organovo, Inc. | Engineered liver tissues, arrays thereof, and methods of making the same |
WO2015017579A1 (en) | 2013-07-31 | 2015-02-05 | Organovo, Inc. | Automated devices, systems, and methods for the fabrication of tissue |
EP3126490B1 (en) | 2014-04-04 | 2020-09-30 | Organovo, Inc. | Engineered three-dimensional breast tissue, adipose tissue, and tumor disease model |
US9814791B2 (en) | 2014-07-01 | 2017-11-14 | Augusta University Research Institute, Inc. | Bio-compatible radiopaque dental fillers for imaging |
US10369248B2 (en) * | 2014-07-29 | 2019-08-06 | The United States Of America As Represented By The Secretary Of The Army | Porous polymer composites |
KR20170064547A (ko) | 2014-10-06 | 2017-06-09 | 오가노보, 인크. | 조작된 신장 조직, 이의 어레이, 및 이를 제조하는 방법 |
FR3030360B1 (fr) * | 2014-12-17 | 2018-07-13 | Universite de Bordeaux | Procede d'impression par laser et dispositif pour sa mise en oeuvre |
WO2016160541A1 (en) | 2015-03-27 | 2016-10-06 | 3M Innovative Properties Company | Fibrin composition, method and wound articles |
US11077169B2 (en) * | 2015-07-22 | 2021-08-03 | Temple University-Of The Commonwealth System Of Higher Education | Soy-derived bioactive peptides for use in compositions and methods for wound healing, tissue engineering, and regenerative medicine |
ITUB20160291A1 (it) * | 2016-02-01 | 2017-08-01 | Oxidea Soc A Responsabilita Limitata Semplificata | Preparazione riassorbibile per usi medicali, e usi particolari di tale preparazione |
WO2017151634A1 (en) * | 2016-02-29 | 2017-09-08 | The Regents Of The University Of California | Fluorescent and/or nir coatings for medical objects, object recovery systems and methods |
CN106039380A (zh) * | 2016-06-28 | 2016-10-26 | 邯郸沃伦多科技开发有限公司 | 一种组织创面修复材料及其相关产品制备方法 |
KR102005737B1 (ko) * | 2016-09-28 | 2019-07-31 | 포항공과대학교 산학협력단 | 신규한 3d 바이오 프린팅용 바이오 잉크 및 이의 이용 |
KR20180038356A (ko) * | 2016-10-06 | 2018-04-16 | 서울과학기술대학교 산학협력단 | 기계적 물성이 우수한 고분자-세라믹 하이브리드 필름 및 이의 제조방법 |
WO2018066780A2 (ko) * | 2016-10-06 | 2018-04-12 | 서울과학기술대학교 산학협력단 | 기계적 물성과 탄성을 가진 고분자-세라믹 하이브리드 필름 및 이의 제조방법 |
CN108261564A (zh) * | 2016-12-30 | 2018-07-10 | 深圳兰度生物材料有限公司 | 脱细胞外基质及其制备方法和应用 |
CN107320774B (zh) * | 2017-06-16 | 2020-04-07 | 卓阮医疗科技(苏州)有限公司 | 一种拼接生物材料及其制备方法 |
DE102017115672B4 (de) * | 2017-07-12 | 2020-08-27 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Isotropes Hydroxylapatit/Gelatine-Kompositmaterial, Verfahren zu dessen Herstellung und dessen Verwendung |
KR102029388B1 (ko) * | 2017-12-06 | 2019-10-07 | 한국세라믹기술원 | 레반/HAp 유무기 하이브리드 필러 및 이의 제조방법 |
BR112020015616B1 (pt) * | 2018-01-31 | 2023-11-21 | Rokit Healthcare Inc | Composição de biotinta para folha de regeneração de derme, método para fabricar folha de regeneração de derme customizada usando a mesma e folha de regeneração de derme customizada fabricada usando o método de fabricação |
CN108310455B (zh) * | 2018-03-20 | 2021-07-30 | 嘉兴尔云信息科技有限公司 | 纳米羟基磷灰石、pgs-m复合骨修复材料及其制备方法 |
US11998654B2 (en) | 2018-07-12 | 2024-06-04 | Bard Shannon Limited | Securing implants and medical devices |
CA3103709A1 (en) * | 2018-07-16 | 2020-01-23 | Christopher Caputo | Colorimetric sensors and methods and uses thereof |
CN108912635B (zh) * | 2018-07-31 | 2020-07-24 | 南通嘉得利安全用品有限公司 | 一种绝缘防护手套的制备方法 |
Family Cites Families (58)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2385802A (en) * | 1942-02-09 | 1945-10-02 | Research Corp | Process for the manufacture of plastics |
US2385803A (en) | 1942-02-09 | 1945-10-02 | Research Corp | Process for the manufacture of plastic compositions |
US2533004A (en) | 1943-10-27 | 1950-12-05 | John D Ferry | Fibrin clots and methods for preparing the same |
US2492458A (en) | 1944-12-08 | 1949-12-27 | Jr Edgar A Bering | Fibrin foam |
US2576006A (en) | 1947-11-29 | 1951-11-20 | Research Corp | Methods of forming shaped fibrin products |
US3523807A (en) | 1966-11-25 | 1970-08-11 | Mihaly Gerendas | Method of making a cross-linked fibrin prosthesis |
US4188373A (en) | 1976-02-26 | 1980-02-12 | Cooper Laboratories, Inc. | Clear, water-miscible, liquid pharmaceutical vehicles and compositions which gel at body temperature for drug delivery to mucous membranes |
US4352883A (en) | 1979-03-28 | 1982-10-05 | Damon Corporation | Encapsulation of biological material |
JPS61178927A (ja) * | 1981-06-25 | 1986-08-11 | セラフアルム ジ−エムビ−エイチ アンド カンパニ− ケイジイ | フイブリノゲンを含有する乾燥製剤およびその製法 |
US4495174A (en) | 1982-06-21 | 1985-01-22 | Research Corporation | Anesthetic polyorganophosphazenes |
US4440921A (en) | 1982-06-21 | 1984-04-03 | Research Corporation | Coupling of polyorganophosphazenes to carboxylic acid |
US4474753A (en) | 1983-05-16 | 1984-10-02 | Merck & Co., Inc. | Topical drug delivery system utilizing thermosetting gels |
US4478822A (en) | 1983-05-16 | 1984-10-23 | Merck & Co., Inc. | Drug delivery system utilizing thermosetting gels |
US4474752A (en) | 1983-05-16 | 1984-10-02 | Merck & Co., Inc. | Drug delivery system utilizing thermosetting gels |
US4474751A (en) | 1983-05-16 | 1984-10-02 | Merck & Co., Inc. | Ophthalmic drug delivery system utilizing thermosetting gels |
US4548736A (en) | 1983-08-29 | 1985-10-22 | Wisconsin Alumni Research Foundation | Preparation of protein films |
MX163953B (es) * | 1984-03-27 | 1992-07-03 | Univ New Jersey Med | Procedimiento para preparar una matriz biodegradable a base de colageno |
US4880622A (en) | 1986-05-20 | 1989-11-14 | Research Corporation Technologies, Inc. | Water-soluble phosphazene polymers having pharmacological applications |
JPS6423861A (en) * | 1987-07-17 | 1989-01-26 | Suntory Ltd | Gelatinous food |
US4956178A (en) | 1988-07-11 | 1990-09-11 | Purdue Research Foundation | Tissue graft composition |
US4902508A (en) | 1988-07-11 | 1990-02-20 | Purdue Research Foundation | Tissue graft composition |
US5410016A (en) | 1990-10-15 | 1995-04-25 | Board Of Regents, The University Of Texas System | Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers |
AU8702491A (en) * | 1990-11-08 | 1992-05-14 | Matrix Pharmaceutical, Inc. | Fibrin/collagen membrane material for biomedical use |
US5281422A (en) | 1991-09-24 | 1994-01-25 | Purdue Research Foundation | Graft for promoting autogenous tissue growth |
AU683834B2 (en) | 1991-12-31 | 1997-11-27 | Zymogenetics Inc. | Methods for producing thrombin |
US5527692A (en) | 1991-12-31 | 1996-06-18 | Zymogenetics, Inc. | Methods for producing thrombin |
US5352463A (en) | 1992-11-13 | 1994-10-04 | Badylak Steven F | Tissue graft for surgical reconstruction of a collagenous meniscus and method therefor |
US6653291B1 (en) | 1992-11-13 | 2003-11-25 | Purdue Research Foundation | Composition and method for production of transformed cells |
AU709134B2 (en) | 1994-05-02 | 1999-08-19 | E.R. Squibb & Sons, Inc. | Recombinant fibrin chains, fibrin and fibrin-homologs |
US5523293A (en) * | 1994-05-25 | 1996-06-04 | Iowa State University Research Foundation, Inc. | Soy protein-based thermoplastic composition for preparing molded articles |
US6074663A (en) | 1995-01-16 | 2000-06-13 | Baxter International Inc. | Method of using cross-linked fibrin material |
US6485723B1 (en) | 1995-02-10 | 2002-11-26 | Purdue Research Foundation | Enhanced submucosal tissue graft constructs |
US5695998A (en) | 1995-02-10 | 1997-12-09 | Purdue Research Foundation | Submucosa as a growth substrate for islet cells |
EP0820301B1 (en) | 1995-04-07 | 2002-07-24 | Purdue Research Foundation | Tissue graft for urinary bladder reconstruction |
US5711969A (en) | 1995-04-07 | 1998-01-27 | Purdue Research Foundation | Large area submucosal tissue graft constructs |
US5554389A (en) | 1995-04-07 | 1996-09-10 | Purdue Research Foundation | Urinary bladder submucosa derived tissue graft |
US5755791A (en) | 1996-04-05 | 1998-05-26 | Purdue Research Foundation | Perforated submucosal tissue graft constructs |
US7435425B2 (en) * | 2001-07-17 | 2008-10-14 | Baxter International, Inc. | Dry hemostatic compositions and methods for their preparation |
AU731768B2 (en) | 1996-09-16 | 2001-04-05 | Purdue Research Foundation | Composition and method for repairing neurological tissue |
DE69734218T2 (de) | 1996-12-10 | 2006-07-06 | Purdue Research Foundation, West Lafayette | Gewebetransplantat aus der Magensubmukosa |
DK0954254T3 (da) | 1996-12-10 | 2005-01-31 | Cook Biotech Inc | Rörformede transplantater af renset submucosa |
CA2274902C (en) | 1996-12-10 | 2011-02-01 | Purdue Research Foundation | Submucosa extracts |
CA2274033C (en) | 1996-12-10 | 2010-05-11 | Purdue Research Foundation | Biomaterial derived from vertebrate liver tissue |
US6037457A (en) | 1997-01-31 | 2000-03-14 | The University Of North Carolina At Chapel Hill | Method for recombinant fibrinogen production |
US6331319B1 (en) | 1997-09-11 | 2001-12-18 | Purdue Research Foundation | Galactosidase modified submucosal tissue |
AT407117B (de) * | 1997-09-19 | 2000-12-27 | Immuno Ag | Fibrinschwamm |
US6143293A (en) | 1998-03-26 | 2000-11-07 | Carnegie Mellon | Assembled scaffolds for three dimensional cell culturing and tissue generation |
ES2262340T3 (es) | 1998-09-24 | 2006-11-16 | Pharming Intellectual Property Bv | Purificacion del fibrinogeno de la leche mediante el uso de cromatografia de intercambio cationico. |
JP2000125855A (ja) * | 1998-10-21 | 2000-05-09 | Gunze Ltd | 人工皮膚 |
BE1012536A3 (fr) * | 1998-11-04 | 2000-12-05 | Baxter Int | Element muni d'une couche de fibrine sa preparation et son utilisation. |
US6165486A (en) | 1998-11-19 | 2000-12-26 | Carnegie Mellon University | Biocompatible compositions and methods of using same |
US6730299B1 (en) * | 1999-07-21 | 2004-05-04 | Imedex Biomateriaux | Adhesive protein foam for surgical and/or therapeutic uses |
CA2402000A1 (en) * | 2000-03-06 | 2001-09-13 | Tei Biosciences, Inc. | Injectable bio-compatible material and methods of use |
JP2003265593A (ja) * | 2002-03-15 | 2003-09-24 | Yasuhiko Tabata | 生体組織再生用繊維材料 |
US20050137512A1 (en) * | 2003-12-23 | 2005-06-23 | Campbell Todd D. | Wound dressing and method for controlling severe, life-threatening bleeding |
AU2003257179A1 (en) * | 2002-08-02 | 2004-02-23 | Gp Medical | Drug-loaded biological material chemically treated with genipin |
JP2005046228A (ja) * | 2003-07-30 | 2005-02-24 | Chisso Corp | マット及びそれを用いた医療品 |
US20070213768A1 (en) * | 2003-10-21 | 2007-09-13 | Irena Wasserman | Compositions and Devices Including Same Useful for Anastomosis |
-
2006
- 2006-07-28 EP EP09004700A patent/EP2093256A3/en not_active Withdrawn
- 2006-07-28 WO PCT/US2006/029754 patent/WO2007126411A2/en active Application Filing
- 2006-07-28 JP JP2008524266A patent/JP5475283B2/ja active Active
- 2006-07-28 CA CA2616865A patent/CA2616865C/en active Active
- 2006-07-28 EP EP06851119A patent/EP1934288A2/en not_active Withdrawn
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2009502364A5 (ja) | ||
CN101151150B (zh) | 聚乙醇酸树脂类叠层片及其制备方法 | |
JP2007091954A (ja) | 発泡体、その製造方法、およびその再生方法 | |
US20160206745A1 (en) | Three dimensional soy protein-containing scaffolds and methods for their use and production | |
HU218832B (hu) | Biológiai úton lebomlani képes műanyagokból készült habosított anyag és eljárás habosított termékek előállítására ezek alkalmazásával | |
JP4584146B2 (ja) | α−1,4−グルカンおよび/またはその修飾物を含む成型物およびその製造方法 | |
CA2737706A1 (en) | Biodegradable polymer encapsulated microsphere particulate film and method of making thereof | |
KR20130006834A (ko) | 피부 및 상처 보호를 위한 실크 필름의 제조방법 | |
CN107213526A (zh) | 一种用于组织工程的三维复合多孔支架及其制备方法 | |
RU2011125662A (ru) | Адсорбирующее медицинское тело, в частности для удаления раневых жидкостей из полостей тела человека и животных, и способ его изготовления | |
US20040247752A1 (en) | Tubular food envelope containing starch and having a transferable coating, and method for producing the same | |
CN101176799A (zh) | 一种致孔剂粘结滤出法制备组织工程用聚合物多孔支架的方法 | |
Chen et al. | Designing biomimetic scaffolds for skin tissue engineering | |
Bertuzzi et al. | Standard and new processing techniques used in the preparation of films and coatings at the lab level and scale-up | |
CN108498872A (zh) | 一种引导组织再生膜及其制备方法 | |
De Moraes et al. | Biopolymer membranes and films: health, food, environment, and energy applications | |
Labus et al. | Biodegradable polylactide and thermoplastic starch blends as drug release device–mass transfer study | |
Bierhalz et al. | Fundamentals of two-dimensional films and membranes | |
JP5801162B2 (ja) | 生分解性プラスチックおよびその製造方法 | |
US6635684B2 (en) | Method for preparing hydrophilic porous polymeric materials | |
De Carvalho et al. | Biomedical applications for thermoplastic starch | |
JP5852357B2 (ja) | 徐放剤、徐放器、及び徐放剤の製造方法 | |
JP5828643B2 (ja) | ゼラチン水溶液を用いた弾性に富む繊維ならびに中空糸の乾式紡糸法 | |
Ratnaparkhi et al. | Nanofibers-a newer technology | |
JP2008272453A (ja) | 多孔質体の製造方法およびその用途 |